Phase 4 Stroke Trial, Recruiting NCT06486792 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Stroke
Back to Stroke

Phase 4 Stroke Trial, Recruiting

NCT06486792
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 65 or older who have had a stroke caused by a blockage in the brain within the last 15 days, confirmed by an MRI or CT scan
  • People who have not been previously diagnosed with atrial fibrillation (an irregular heartbeat), and where no atrial fibrillation was detected during their hospital stay
  • People where atrial fibrillation is suspected based on one or more of the following: multiple strokes across different areas of the brain; a single stroke plus blockages found in other organs like the kidneys, spleen, or limbs; certain heart measurements or test results suggesting irregular heart activity (confirm with trial site for specific values); or people aged 80 or older who have had a single stroke
  • People who have a plan in place to monitor their heart rhythm over a long period, such as a wearable heart monitor or an implanted recording device
  • People whose level of disability after stroke is rated 4 or below on a standard scale (meaning they may need some help with daily activities but are not completely dependent)
  • People who have given their written agreement to take part in the trial
  • People who are enrolled in the French social security system

Who may not be able to join:

  • People whose stroke already has a clearly identified cause, based on a specific medical classification system used by doctors (confirm with trial site)
  • People who have had a brain bleed that caused symptoms (the presence of very small, silent bleeds on a specialised scan alone does not automatically exclude someone)
  • People with high blood pressure that is not under control, as judged by the treating doctor
  • People for whom there is already a clear medical reason to take blood-thinning or anti-clotting medication
  • People for whom blood-thinning or anti-clotting medication is medically not suitable
  • People with another serious illness that might affect the trial results or prevent them from attending follow-up visits
  • People already taking part in another clinical trial involving a treatment intervention
  • People of childbearing potential who are not using contraception
  • People who are under legal guardianship or a court-appointed support arrangement

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 1 40 25 87 25

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
18 June 2025
Est. completion
18 December 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Occurrence of fatal or nonfatal ischemic stroke, or peripheral emboli (even if asymptomatic) [peripheral emboli: emboli in arm or leg, new renal, splenic, hepatic, mesenteric infarction]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov